Epsilon M&A Deal Report - Homeperf

Transaction Multiples for the Valuation of Private Companies

Sapio Santé France > Homeperf

Announced Date : 14 May 2020

Type : Exit ,Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Sapio Santé France

Target: Homeperf

Target Country: France

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Founded in 1997 by Gaël Donadey, Homeperf provides home healthcare services specializing in the INI sector (Infusion, Nutrition, Insulin therapy).

 

> In order to meet the market demand, the group entered the respiratory market (oxygen therapy, assisted ventilation, sleep apnea) in 2011.

 

> Offers:

  • a range of services, which include remote assistance, nutritional monitoring, smoking cessation, training for the prevention of infectious risk, home artificial nutrition, TV assistance and security support, and informati ...

No EMAT : 120642

Transaction multiples available

EV/Sales EV/Gross Profit EV/EBITDA EV/EBIT Eq/PBT P/E Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226

Example of comparable transactions on EMAT (same sub-sector):

Date Acquirer Target Country Multiples See details
02/06/2020 Santé Cie PolePerf France 0
01/03/2022 Bastide le Confort Médical Maxicare France 0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

Subscribe to EMAT database